| Application no. and date | 02792887.8 (espacenet) (Federated) (European Patent Register), 20021204 | | Patent/reg. no. and date | DK/EP 1450770, 20050330 | | Publication date | 20040901 | | Priority no. and date | GB 0129117, 20011205 | | EP pub. no. and date |
EP 1450770 20040901 | | Effective date | | | Applicant/owner | Glaxo Group Limited, 980 Great West Road
Brentford, Middlesex TW8 9GS, GB | | Applicant ref. no. | P200500354 EP DK | | Inventor | Baker, Robert William, GlaxoSmithKline,
Park Road
Ware,
Hertfordshire SG12 0DP, GB,
Dow, Alan David, GlaxoSmithKline,
Park Road
Ware,
Hertfordshire SG12 0DP, GB,
Summers, Simon John, GlaxoSmithKline,
Park Road
Ware,
Hertfordshire SG12 0DP, GB,
Westrup, Julian,
GlaxoSmithKline, New Frontiers Science Park South,
Third Avenue
Harlow,
Essex CM19 5AW, GB | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/00 (2006.01) , A61K 9/22 (2006.01) , A61K 9/46 (2006.01) | | Title | Farmaceutisk præparat, der omfatter en 5HT1-receptoragonist | | Int. application no. | EP2002013715 | | Int. publication no. | WO2003047552 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
